Patents by Inventor Claudio CIFERRI

Claudio CIFERRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS
    Publication number: 20240094194
    Abstract: Provided herein are methods of treating or preventing human cytomegalovirus (HCMV) infection comprising modulating interactions between the HCMV gH/gL/UL128-131A pentamer and plasma membrane-expressed host cell proteins, as well as methods of identifying modulators of such interactions.
    Type: Application
    Filed: November 24, 2023
    Publication date: March 21, 2024
    Inventors: Claudio CIFERRI, Evan Michael Green, Marc Kschonsak
  • METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS
    Publication number: 20230295273
    Abstract: Provided herein are methods of treating or preventing human cytomegalovirus (HCMV) infection comprising modulating interactions between the HCMV gHgLgO trimer and plasma membrane-expressed host cell proteins, as well as methods of identifying modulators of such interactions.
    Type: Application
    Filed: May 26, 2023
    Publication date: September 21, 2023
    Inventors: Claudio CIFERRI, Marc KSCHONSAK
  • IMMUNOGLOBULIN A ANTIBODIES AND METHODS OF PRODUCTION AND USE
    Publication number: 20220048990
    Abstract: The presently disclosed subject matter provides antibodies, e.g., IgA antibodies and IgG-IgA fusion molecules, and compositions comprising such antibodies, as well as methods of making and using such antibodies and compositions.
    Type: Application
    Filed: July 20, 2021
    Publication date: February 17, 2022
    Applicant: GENENTECH, INC.
    Inventors: Twyla Noelle Lombana, Julie A. Zorn, Marissa L. Matsumoto, Christoph Spiess, Claudio Ciferri, Alberto Estevez
  • Mammalian cells expressing cytomegalovirus antigens
    Patent number: 10414802
    Abstract: This invention relates to cytomegalovirus (CMV) proteins suitable for vaccine uses. Provided herein are mammalian host cells, in particular CHO cells, in which the sequence(s) encoding CMV proteins gH, gL, pUL128, pUL130, pUL131 (or a complex-forming fragment thereof) are stably integrated into the genome.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: September 17, 2019
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Andrea Carfi, Claudio Ciferri, Irmgard Hofmann, Holger Laux, Anders Lilja, Yingxia Wen
  • CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF
    Publication number: 20190276498
    Abstract: The disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.
    Type: Application
    Filed: November 15, 2018
    Publication date: September 12, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Andrea CARFI, Claudio CIFERRI, Yi XING
  • Cytomegalovirus antigens and uses thereof
    Patent number: 10167321
    Abstract: This disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: January 1, 2019
    Assignee: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Andrea Carfi, Claudio Ciferri, Yi Xing
  • CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF
    Publication number: 20170369532
    Abstract: This disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Andrea CARFI, Claudio CIFERRI, Yi XING
  • MAMMALIAN CELLS EXPRESSING CYTOMEGALOVIRUS ANTIGENS
    Publication number: 20170362278
    Abstract: This invention relates to cytomegalovirus (CMV) proteins suitable for vaccine uses. Provided herein are mammalian host cells, in particular CHO cells, in which the sequence(s) encoding CMV proteins gH, gL, pUL128, pUL130, pUL131 (or a complex-forming fragment thereof) are stably integrated into the genome.
    Type: Application
    Filed: October 29, 2015
    Publication date: December 21, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Andrea CARFI, Claudio CIFERRI, Irmgard HOFMANN, Holger LAUX, Anders LILJA, Yingxia WEN